Annual EBITDA:
$233.41M+$11.90M(+5.37%)Summary
- As of today, HRMY annual EBITDA is $233.41 million, with the most recent change of +$11.90 million (+5.37%) on December 31, 2024.
- During the last 3 years, HRMY annual EBITDA has risen by +$152.95 million (+190.09%).
- HRMY annual EBITDA is now at all-time high.
Performance
HRMY EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$71.45M+$17.31M(+31.96%)Summary
- As of today, HRMY quarterly EBITDA is $71.45 million, with the most recent change of +$17.31 million (+31.96%) on September 30, 2025.
- Over the past year, HRMY quarterly EBITDA has increased by +$3.78 million (+5.58%).
- HRMY quarterly EBITDA is now at all-time high.
Performance
HRMY Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$249.51M+$3.78M(+1.54%)Summary
- As of today, HRMY TTM EBITDA is $249.51 million, with the most recent change of +$3.78 million (+1.54%) on September 30, 2025.
- Over the past year, HRMY TTM EBITDA has increased by +$49.95 million (+25.03%).
- HRMY TTM EBITDA is now at all-time high.
Performance
HRMY TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
HRMY EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +5.4% | +5.6% | +25.0% |
| 3Y3 Years | +190.1% | +297.8% | +102.4% |
| 5Y5 Years | +263.6% | +478.7% | +1554.6% |
HRMY EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +190.1% | at high | +297.8% | at high | +102.4% |
| 5Y | 5-Year | at high | +263.6% | at high | +488.5% | at high | +1554.6% |
| All-Time | All-Time | at high | +263.6% | at high | +213.3% | at high | +403.6% |
HRMY EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $71.45M(+32.0%) | $249.51M(+1.5%) |
| Jun 2025 | - | $54.15M(-13.0%) | $245.73M(+12.2%) |
| Mar 2025 | - | $62.21M(+0.8%) | $218.99M(+1.9%) |
| Dec 2024 | $233.41M(+5.4%) | $61.70M(-8.8%) | $214.94M(+7.7%) |
| Sep 2024 | - | $67.68M(+146.9%) | $199.56M(-1.5%) |
| Jun 2024 | - | $27.41M(-52.9%) | $202.50M(-11.2%) |
| Mar 2024 | - | $58.16M(+25.6%) | $228.06M(+5.4%) |
| Dec 2023 | $221.51M(+50.8%) | $46.32M(-34.4%) | $216.39M(-3.3%) |
| Sep 2023 | - | $70.61M(+33.3%) | $223.75M(+30.8%) |
| Jun 2023 | - | $52.97M(+13.9%) | $171.10M(+8.8%) |
| Mar 2023 | - | $46.49M(-13.4%) | $157.30M(+9.6%) |
| Dec 2022 | $146.87M | $53.68M(+198.8%) | $143.57M(+16.5%) |
| Sep 2022 | - | $17.96M(-54.1%) | $123.28M(-5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $39.17M(+19.6%) | $131.04M(+9.3%) |
| Mar 2022 | - | $32.76M(-1.9%) | $119.91M(+12.7%) |
| Dec 2021 | $80.46M(+5218.0%) | $33.39M(+29.8%) | $106.37M(+25.0%) |
| Sep 2021 | - | $25.73M(-8.3%) | $85.12M(+18.6%) |
| Jun 2021 | - | $28.04M(+46.0%) | $71.74M(+32.5%) |
| Mar 2021 | - | $19.21M(+58.2%) | $54.16M(+99.0%) |
| Dec 2020 | $1.51M(+101.1%) | $12.14M(-1.7%) | $27.22M(+80.5%) |
| Sep 2020 | - | $12.35M(+18.1%) | $15.08M(+451.8%) |
| Jun 2020 | - | $10.46M(+235.4%) | $2.73M(+110.2%) |
| Mar 2020 | - | -$7.73M(+59.6%) | -$26.87M(+67.3%) |
| Dec 2019 | -$142.69M(-245.9%) | - | - |
| Jun 2019 | - | -$19.14M(+69.6%) | -$82.19M(-30.4%) |
| Mar 2019 | - | -$63.05M | -$63.05M |
| Dec 2018 | -$41.26M | - | - |
FAQ
- What is Harmony Biosciences Holdings, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Harmony Biosciences Holdings, Inc.?
- What is Harmony Biosciences Holdings, Inc. annual EBITDA year-on-year change?
- What is Harmony Biosciences Holdings, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Harmony Biosciences Holdings, Inc.?
- What is Harmony Biosciences Holdings, Inc. quarterly EBITDA year-on-year change?
- What is Harmony Biosciences Holdings, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Harmony Biosciences Holdings, Inc.?
- What is Harmony Biosciences Holdings, Inc. TTM EBITDA year-on-year change?
What is Harmony Biosciences Holdings, Inc. annual EBITDA?
The current annual EBITDA of HRMY is $233.41M
What is the all-time high annual EBITDA for Harmony Biosciences Holdings, Inc.?
Harmony Biosciences Holdings, Inc. all-time high annual EBITDA is $233.41M
What is Harmony Biosciences Holdings, Inc. annual EBITDA year-on-year change?
Over the past year, HRMY annual EBITDA has changed by +$11.90M (+5.37%)
What is Harmony Biosciences Holdings, Inc. quarterly EBITDA?
The current quarterly EBITDA of HRMY is $71.45M
What is the all-time high quarterly EBITDA for Harmony Biosciences Holdings, Inc.?
Harmony Biosciences Holdings, Inc. all-time high quarterly EBITDA is $71.45M
What is Harmony Biosciences Holdings, Inc. quarterly EBITDA year-on-year change?
Over the past year, HRMY quarterly EBITDA has changed by +$3.78M (+5.58%)
What is Harmony Biosciences Holdings, Inc. TTM EBITDA?
The current TTM EBITDA of HRMY is $249.51M
What is the all-time high TTM EBITDA for Harmony Biosciences Holdings, Inc.?
Harmony Biosciences Holdings, Inc. all-time high TTM EBITDA is $249.51M
What is Harmony Biosciences Holdings, Inc. TTM EBITDA year-on-year change?
Over the past year, HRMY TTM EBITDA has changed by +$49.95M (+25.03%)